Provider Comparison
Each provider is rated on a 10-point scale across 6 weighted criteria: Value (20%) · Transparency (15%) · Support & Coaching (20%) · Shipping & Convenience (15%) · Education & Wellness (15%) · Intake Process (15%). Scores are updated monthly. Coupon codes are verified where possible but may expire — always confirm at checkout.
Tirzepatide Dose Pricing Comparison
| Provider ▼ | GLP Score | 2.5mg | 5.0mg | 7.5mg | 10mg | 12.5mg | 15mg |
|---|
Daily Protein & Water Intake Calculator
Adequate protein and hydration are especially important while on GLP-1 medications to preserve lean muscle mass and support your body during weight loss.
Important Disclaimer
All bodies are different. These are general estimates based on commonly referenced guidelines. Always consult your physician or a registered dietitian before making significant changes to your diet, especially while on GLP-1 medications.
How Compounding Pharmacies Are Changing Healthcare
Compounding pharmacies are playing an increasingly important role in modern healthcare by bridging gaps that traditional one-size-fits-all manufacturing can't always fill. Here's how they're reshaping access to personalized medicine.
Individualized Medicine
Not every patient responds the same way to the same dose. Compounding pharmacies work directly with prescribers to tailor medications to individual needs — adjusting dosage strengths, combining active ingredients, or creating formulations that remove allergens and unnecessary fillers.
Bridging the Access Gap
When brand-name medications face shortages, are discontinued, or are priced beyond reach for many patients, compounding pharmacies step in. They provide an essential safety net that keeps patients on their treatment plans without interruption — especially for those without insurance coverage.
503A & 503B Oversight
Licensed compounding pharmacies operate under strict FDA-regulated frameworks. 503A pharmacies fill individual prescriptions under state oversight. 503B outsourcing facilities operate under direct FDA registration with current good manufacturing practice (cGMP) requirements, batch testing, and adverse event reporting.
Personalized Dosing & Titration
Mass-manufactured medications come in fixed dose sizes. Compounders can create precise, incremental doses that allow patients and their providers to fine-tune titration schedules — reducing side effects and finding the optimal therapeutic dose faster.
Patient-Centered Innovation
Compounding pharmacies are at the forefront of patient-centered care. From creating allergen-free formulations to developing alternative delivery methods for patients who can't tolerate standard forms, they solve real problems that large-scale manufacturing often overlooks.
Telehealth & Modern Access
The rise of telehealth has made compounded medications more accessible than ever. Patients can now consult with licensed providers from home and have personalized medications shipped directly to their door — eliminating geographic barriers to quality care.
Compounding has been a cornerstone of pharmacy practice for centuries. Today's licensed compounding pharmacies combine that tradition with modern quality standards, third-party testing, and physician oversight to deliver safe, effective, individualized medications.
Understanding Compounded Tirzepatide
What is Compounded Tirzepatide?
Compounded tirzepatide is a custom-prepared version of the GLP-1/GIP receptor agonist medication. It is made by licensed 503A or 503B compounding pharmacies according to a doctor's prescription, offering patients an individualized approach to their treatment plan.
Tirzepatide works by activating two hormone receptors:
- GLP-1 receptor: Reduces appetite, slows gastric emptying, and improves blood sugar control
- GIP receptor: Enhances the GLP-1 effect, leading to greater weight loss compared to GLP-1-only medications
This dual-action mechanism makes tirzepatide one of the most effective weight loss medications available, with clinical trials showing average weight loss of 20-22% of body weight at the highest doses.
Injectable Tirzepatide: The Standard
Injectable Tirzepatide is the standard formulation available from compounding providers. Self-administered once weekly via subcutaneous injection, it is well-established, reliable, and the most widely available option. All providers listed on this site currently offer injectable tirzepatide.
How to Choose a Compounded Tirzepatide Provider
When evaluating tirzepatide providers, consider these key factors:
- Pharmacy Licensing: Ensure they use 503A or 503B licensed pharmacies. These follow strict FDA guidelines for compounding.
- Cost: Compare monthly prices at your target dose. Prices range from $133-$550+ per month depending on the provider and dose.
- Medical Review: Reputable providers require a telehealth consultation with a licensed physician before prescribing.
- Shipping & Support: Check for free shipping, cold pack delivery, and customer support quality.
- Guarantees: Look for satisfaction guarantees, refund policies, or weight loss guarantees (10% loss in X months).
Understanding Tirzepatide Dose Levels
Tirzepatide is dosed in a gradual titration schedule to minimize side effects and find your optimal dose:
- 2.5mg (Starting dose): Used for the first 4 weeks. Allows your body to adjust and assess tolerance.
- 5.0mg: Increased after 4 weeks. This is often where significant weight loss begins for many people.
- 7.5mg: Increased at 4-week intervals. Many people reach their goal dose here.
- 10mg: Further increase for greater effect. Nausea and side effects typically plateau by this dose.
- 12.5mg: High-dose option. Used for individuals who need more aggressive weight loss.
- 15mg (Maximum dose): The highest approved dose. Most effective for maximum weight loss but highest side effect risk.
Most people find their optimal dose between 7.5mg-12.5mg. It's important to work with your provider to find the dose that balances weight loss with side effect tolerance.
Beyond Weight Loss: Tirzepatide Research & Approved Uses
Tirzepatide's dual GLP-1/GIP mechanism has attracted significant clinical interest beyond its original weight management approval. Here's what the latest research shows across multiple areas of health.
Currently FDA-Approved
Type 2 Diabetes (Mounjaro) — Approved May 2022
The original indication. Tirzepatide is a first-in-class dual GLP-1/GIP receptor agonist that improves blood sugar control in adults with type 2 diabetes as an adjunct to diet and exercise.
Chronic Weight Management (Zepbound) — Approved November 2023
Approved for adults with obesity or overweight with at least one weight-related condition. Clinical trials demonstrated average weight loss of 20-22% of body weight at higher doses.
Obstructive Sleep Apnea (Zepbound) — Approved December 2024
The first prescription medication approved for moderate-to-severe OSA in adults with obesity. Trials showed significant reductions in apnea episodes alongside 17-20% body weight reduction.
Active Clinical Trials & Promising Research
Liver Disease (MASH/NASH) — Phase 3 Results Published 2024
The SYNERGY-NASH trial found that 73% of patients on 15mg tirzepatide achieved MASH resolution without fibrosis worsening, compared to just 13% on placebo. Over half also saw measurable improvement in liver fibrosis staging.
Heart Failure (HFpEF) — Phase 3 Results Published 2024
The SUMMIT trial showed tirzepatide reduced the combined risk of cardiovascular death or worsening heart failure events (9.9% vs 15.3% with placebo) in patients with heart failure with preserved ejection fraction and obesity.
Cardiovascular Protection — SURPASS-CVOT Results 2025
In a 4-year trial of patients with type 2 diabetes and cardiovascular disease, tirzepatide showed meaningful reductions in major adverse cardiovascular events. Observational data suggests potential benefits for overall mortality, stroke risk, and heart failure hospitalizations.
Chronic Kidney Disease — Multiple Trials Active
Early data from SURPASS-CVOT showed slower kidney function decline with tirzepatide. The dedicated TREASURE-CKD trial is now investigating benefits in chronic kidney disease patients both with and without diabetes.
Polycystic Ovary Syndrome (PCOS) — Active Trials & Real-World Data
Real-world data presented in 2025 showed promising results in women with PCOS: menstrual regularity improved significantly, ovarian cyst presence decreased substantially, and insulin resistance markers improved. Formal clinical trials are ongoing.
Knee Osteoarthritis — Phase 3 Trial Ongoing
The STOP KNEE-OA trial is studying tirzepatide for knee osteoarthritis in patients with obesity. Early data shows associations with reduced joint pain, lower NSAID use, and potential anti-inflammatory effects beyond weight reduction alone.
Early-Stage & Observational Research
Neurodegenerative Disease (Alzheimer's & Parkinson's)
Preclinical studies show GLP-1 receptor agonists may cross the blood-brain barrier and offer neuroprotective effects. While formal tirzepatide-specific trials have not yet launched, the broader GLP-1 class is being actively studied for cognitive decline and early Alzheimer's disease.
Type 1 Diabetes
A Phase 2 trial published in 2024 demonstrated tirzepatide's potential for weight loss in adults with type 1 diabetes and obesity, marking the first study of its kind in this population.
Alcohol Use Disorder
Observational analyses of large patient databases suggest GLP-1/GIP medications may be associated with reduced incidence of alcohol use disorder. Mechanism and causality are still under investigation.
Research Disclaimer
The information above is provided for educational purposes only and reflects publicly available clinical research as of April 2026. Off-label use of any medication should only be considered under the direct supervision of a licensed healthcare provider. GLP1 Provider Comparison does not recommend or endorse off-label use of tirzepatide.
Next-Gen Formats: Oral & ODT Tirzepatide
We're tracking the development of oral tablet and orally disintegrating tablet (ODT) formulations of compounded tirzepatide. As these formats become available through licensed compounding pharmacies, we'll add them to our comparison tools and provider database. Currently, most providers offer injectable tirzepatide, which remains the most established and effective delivery method. Check back soon for updates on new formats!
Frequently Asked Questions
Insights & Editorials
Stay informed with the latest developments in compounded tirzepatide, pricing trends, regulatory updates, and practical guidance for your weight loss journey.
Compounded Tirzepatide Pricing in 2026: What's Changed and What to Expect
After the FDA resolved the tirzepatide shortage, the compounding landscape shifted significantly. We break down how pricing has evolved across 15 providers, which dose levels saw the biggest changes, and what the second half of 2026 may bring for patients seeking affordable access.
FDA Compounding Rules in 2026: What Patients Need to Know
The regulatory environment around compounded GLP-1 medications continues to evolve. We explain the current status of 503A and 503B pharmacy rules, what the end of the shortage declaration means for access, and how to verify your provider is operating within legal guidelines.
Your First 12 Weeks on Tirzepatide: A Realistic Timeline
What should you actually expect during the titration process? We walk through the standard 2.5mg → 5mg → 7.5mg schedule, common side effects at each stage, average weight loss timelines from clinical data, and practical tips from patients who've been through it.
How Compounding Pharmacies Are Making Healthcare More Personal
From individualized dosing to allergen-free formulations, compounding pharmacies are filling gaps that traditional manufacturing can't. We explore 503A and 503B oversight, quality standards, the role of telehealth in expanding access, and what to look for when choosing a compounding provider.
Oral & ODT Tirzepatide: When Will It Be Available?
Eli Lilly's oral tirzepatide trials are advancing, and some compounding pharmacies are already exploring sublingual and ODT formulations. We look at the current state of non-injectable options, realistic timelines, expected pricing, and what this means for patients who want to skip the needle.
7 Ways to Lower Your Compounded Tirzepatide Costs
From multi-month bundles to HSA/FSA strategies, there are legitimate ways to reduce what you pay. We cover the smartest approaches to saving money without sacrificing quality — including which providers offer the best bulk discounts and how dose optimization can impact your bottom line.
Our Methodology
GLP1 Provider Comparison is an independent, unbiased comparison resource for compounded tirzepatide providers. Here's how we work:
- No Sponsorships: We don't accept payments, affiliate commissions, or sponsorships from any provider.
- Alphabetical Listing: Providers are listed alphabetically to ensure unbiased presentation.
- Public Data: We gather pricing, features, and reviews from publicly available sources and provider websites.
- Regular Updates: We update provider information monthly to reflect pricing and feature changes.
- Tirzepatide Focus: This site focuses exclusively on compounded tirzepatide providers, with next-generation oral and ODT formats tracked for future addition.
- GLP1 Provider Comparison Score Methodology: Each provider is scored on a 10-point scale using 6 weighted criteria: Value (20%), Transparency (15%), Support & Coaching (20%), Shipping & Convenience (15%), Education & Wellness (15%), and Intake Process (15%). Scores are reviewed and updated monthly by the GLP1 Provider Comparison editorial team.
- User Feedback: We welcome corrections and updates from users and providers. Please contact us with any inaccuracies.
Important Disclaimers
This Is Not Medical Advice
The information provided on GLP1 Provider Comparison is for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Nothing on this website should be interpreted as a recommendation to use any specific medication, provider, or treatment plan.
Always consult with a qualified, licensed healthcare provider before starting, changing, or stopping any medication — including compounded tirzepatide. Only a healthcare professional who knows your individual medical history can determine whether tirzepatide is appropriate for you.
Compounded medications are not FDA-approved finished drug products. While compounding pharmacies are regulated, the compounded formulations themselves have not been evaluated by the FDA for safety, efficacy, or quality. Use of compounded medications carries inherent risks that should be discussed with your healthcare provider.
No Paid Partners, Sponsorships, or Affiliate Relationships
GLP1 Provider Comparison has zero paid partnerships, sponsorships, affiliate commissions, or financial relationships with any provider, pharmacy, or medication manufacturer listed on this site. We do not receive compensation of any kind — directly or indirectly — for listing, ranking, or reviewing any provider.
All providers are listed in alphabetical order. No provider has paid for placement, priority listing, featured status, or favorable reviews. Our comparisons are based entirely on publicly available information including published pricing, features, and customer reviews.
This site is operated as an independent, consumer-focused resource. If you believe any information is inaccurate or outdated, please submit a correction so we can update it promptly.
Submit a Correction or Update
Spotted outdated pricing, an expired coupon, or incorrect info? We review every submission and update the site regularly.
We review all submissions and update the site regularly. Your email is never shared or used for marketing.